A win for full-line wholesalers

Pharmaceutical manufacturer ditches direct distribution model for CSO wholesalers in move driven by pharmacist feedback AstraZeneca has announced it will exit its exclusive-direct distribution arrangements and return supply of its PBS medicines to the three full-line CSO wholesalers API, Sigma and Symbion from 1 October 2019. The move will see AstraZeneca medicines available through the